Medical Costs Payable (Details) $ in Millions |
6 Months Ended | |
|---|---|---|
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
|
| Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items] | ||
| Medical costs payable, beginning of period | $ 39,337 | $ 34,224 |
| Reported medical costs: | ||
| Current year | 150,333 | 152,316 |
| Prior years | (1,250) | (320) |
| Changes in premium deficiency and loss contract reserves | (236) | |
| Total reported medical costs | 148,847 | 151,996 |
| Medical payments: | ||
| Payments for current year | (116,846) | (118,793) |
| Payments for prior years | (32,474) | (28,998) |
| Total medical payments | (149,320) | (147,791) |
| Change in medical costs payable included within businesses held for sale | 66 | (2) |
| Medical costs payable, end of period | $ 38,930 | $ 38,427 |
| X | ||||||||||
- Definition Increase in medical costs payable included within businesses held for sale No definition available.
|
| X | ||||||||||
- Definition PremiumDeficiencyAndLossContractsReserves No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|